Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Viking Therapeutics Inc., 3 years.
Viking Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +3,150 | — | — |
| Oct 27, 2025 | Viking Therapeutics Inc. | Grant or award | +16,000 | $4.48 | $71,680 |
| Oct 27, 2025 | Viking Therapeutics Inc. | Grant or award | +22,000 | $5.80 | $127,600 |
| Oct 27, 2025 | Viking Therapeutics Inc. | Grant or award | +22,000 | $4.88 | $107,360 |
| Oct 27, 2025 | Viking Therapeutics Inc. | Open-market sale | −60,000 | $35.57 | $2,134,200 |
| May 16, 2023 | Viking Therapeutics Inc. | Option exercise | +40,000 | $1.08 | $43,200 |
| May 16, 2023 | Viking Therapeutics Inc. | Open-market sale | −40,000 | $25.00 | $1,000,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.